Asia-Pacific Radiopharmaceuticals Market to 2032
Overview
The Asia-Pacific Radiopharmaceuticals Market is expected to reach a 2.89 USD Billion by 2032 and is projected to grow at a CAGR of 5.70% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.85
Forecast, 2032 (USD Billion)
2.89
CAGR, 2024 - 2032
5.70%
Report Coverage
Asia-Pacific
Asia-Pacific Radiopharmaceuticals Market 2018-2032 USD Billion
Asia-Pacific Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.85 USD Billion
- Projected Market Size (2032): 2.89 USD Billion
- CAGR (2025-2032): 5.70%
Key Findings of Asia-Pacific Radiopharmaceuticals Market
- The Asia-Pacific Radiopharmaceuticals Market was valued at 2.89 USD Billion in 2024.
- The Asia-Pacific Radiopharmaceuticals Market is likely to grow at a CAGR of 5.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Generics in Drug Type Segment accounted for the largest share of the market with a revenue of 1.10 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 6.48% during the forecast period from 2024 to 2032.
Asia-Pacific Radiopharmaceuticals Market Scope
Asia-Pacific Radiopharmaceuticals Market Segmentation & Scope
Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
Application
- Diagnostic
- Therapeutic
Source
- Others
- Cyclotrons
- Nuclear Reactors
Drug Type
- Branded
- Generics
Asia-Pacific Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.85 USD Billion |
| Market Value in 2032 | 2.89 USD Billion |
| CAGR (2025-2032) | 5.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,End User,Application,Source,Drug Type |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 1.85 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 365.67 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Radiopharmaceuticals Market to 2032, By Type
- Diagnostic Radiopharmaceuticals is the largest segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a revenue of 1.04 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a Growth rate of 5.86 % in forecast period 2025-2032.
-
Asia-Pacific Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a revenue of 696.32 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a Growth rate of 6.48 % in forecast period 2025-2032.
-
Asia-Pacific Radiopharmaceuticals Market to 2032, By Application
- Diagnostic is the largest segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a revenue of 994.97 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a Growth rate of 5.89 % in forecast period 2025-2032.
-
Asia-Pacific Radiopharmaceuticals Market to 2032, By Source
- Nuclear Reactors is the largest segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a revenue of 777.38 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a Growth rate of 6.18 % in forecast period 2025-2032.
-
Asia-Pacific Radiopharmaceuticals Market to 2032, By Drug Type
- Generics is the largest segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a revenue of 1.10 USD Billion in the year 2024.
- Generics is the Fastest growing segment in Asia-Pacific Radiopharmaceuticals Market to 2032 with a Growth rate of 5.77 % in forecast period 2025-2032.
Asia-Pacific Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE Healthcare | |||
| Lantheus | |||
| Curium | |||
Asia-Pacific Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Radiopharmaceuticals Market is segmented based on Segmentation Type,End User,Application,Source,Drug Type.
Asia-Pacific Radiopharmaceuticals Market was valued at USD 1.85(Revenue in USD Billion) in 2023.
Asia-Pacific Radiopharmaceuticals Market is projected to grow at a CAGR of 5.70% during the forecast period of 2024 to 2032.
The Generics segment is expected to dominate the Asia-Pacific Radiopharmaceuticals Market, holding a largest market share of 1.10 USD Billion in 2024
Asia-Pacific Radiopharmaceuticals Market Scope
Asia-Pacific Radiopharmaceuticals Market Segmentation & Scope
Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
Application
- Diagnostic
- Therapeutic
Source
- Others
- Cyclotrons
- Nuclear Reactors
Drug Type
- Branded
- Generics
Frequently Asked Questions
The Asia-Pacific Radiopharmaceuticals Market is segmented based on Segmentation Type,End User,Application,Source,Drug Type.
Asia-Pacific Radiopharmaceuticals Market was valued at USD 1.85(Revenue in USD Billion) in 2023.
Asia-Pacific Radiopharmaceuticals Market is projected to grow at a CAGR of 5.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Radiopharmaceuticals Market for final year is USD 2.89 (USD Billion).
Asia-Pacific Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Radiopharmaceuticals Market is segmented based on Segmentation Type,End User,Application,Source,Drug Type.
Asia-Pacific Radiopharmaceuticals Market was valued at USD 1.85(Revenue in USD Billion) in 2023.
Asia-Pacific Radiopharmaceuticals Market is projected to grow at a CAGR of 5.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Radiopharmaceuticals Market for final year is USD 2.89 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.